Fusicoccin A (FC)
is a fungal phytotoxin that stabilizes protein–protein
interactions (PPIs) between 14-3-3 adapter proteins and their phosphoprotein
interaction partners. Recently, FC has emerged as an important chemical
probe of human 14-3-3 PPIs involved in cancer and neurobiology. These
previous studies have established the structural requirements for
FC-induced stabilization of 14-3-3·client phosphoprotein complexes;
however, the effect of 14-3-3 isoforms on FC activity remains underexplored.
This is a relevant question for the continued development of FC variants
because there are seven isoforms of 14-3-3 in humans. Despite their
sequence and structural similarities, a growing body of experimental
evidence supports both tissue-specific expression of 14-3-3 isoforms
and isoform-specific functions
in vivo
. Herein, we
interrogate the isoform-specificity profile of FC
in vitro
using recombinant 14-3-3 isoforms and a library of fluorescein-labeled
hexaphosphopeptides mimicking the C-terminal recognition domains of
client proteins that are characterized targets of FC
in vivo
. Our results reveal modest isoform preferences for individual client
phospholigands and demonstrate that FC differentially stabilizes PPIs
involving 14-3-3σ. Together, these data support the feasibility
of developing FC variants with enhanced isoform selectivity.